VIIBRYD (Allergan, Inc.)
Welcome to the PulseAid listing for the VIIBRYD drug offered from Allergan, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergan, Inc. |
| NON-PROPRIETARY NAME: | vilazodone hydrochloride |
| SUBSTANCE NAME: | VILAZODONE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-04-29 |
| END MARKETING DATE: | 0000-00-00 |
VIIBRYD HUMAN PRESCRIPTION DRUG Details:
| Item Description | VIIBRYD from Allergan, Inc. |
| LABELER NAME: | Allergan, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 2011-04-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0456-1110_f180b475-4aa3-4c3d-965e-c7e2e41ad8bb |
| PRODUCT NDC: | 0456-1110 |
| APPLICATION NUMBER: | NDA022567 |
Other VILAZODONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
